RE-BVS – Piemonte Repository

Sfoglia per RIVISTA
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY
Collezione ASL Città di Torino

Items : 7

Effectiveness of dolutegravir-based regimens as either first-line or switch antiretroviral therapy: data from the Icona cohort. in Journal of the International AIDS Society / J Int AIDS Soc. 2019 Jan;22(1):e25227. doi: 10.1002/jia2.25227.

2019
ASL Città di Torino

Mondi A; Cozzi-Lepri A; Tavelli A; Rusconi S; Vichi F; Ceccherini-Silberstein F; Calcagno A; De Luca A; Maggiolo F; Marchetti G; Antinori A; d'Arminio Monforte A;

Increased risk of virological failure to the first antiretroviral regimen in HIV-infected migrants compared to natives: data from the ICONA cohort. in Journal of the International AIDS Society / J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19769. doi: 10.7448/IAS.17.4.19769. eCollection 2014.

2014
ASL Città di Torino

Saracino A; Lorenzini P; Lo Caputo S; Girardi E; Castelli F; Bonfanti P; Galli M; Caramello P; Abrescia N; Mussini C; Monno L; Monforte Ad;

Cerebrospinal fluid biomarkers in patients with plasma HIV RNA below 20 copies/mL. in Journal of the International AIDS Society / J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19719. doi: 10.7448/IAS.17.4.19719. eCollection 2014.

2014
ASL Città di Torino

Calcagno A; Atzori C; Romito A; Ecclesia S; Imperiale D; Audagnotto S; Alberione MC; Trentalange A; Di Perri G; Bonora S;

Treatment outcome in HIV+ patients receiving 3- or 4-drug regimens during PHI. in Journal of the International AIDS Society / J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19778. doi: 10.7448/IAS.17.4.19778. eCollection 2014.

2014
ASL Città di Torino

Bottani GM; Oreni ML; Orofino G; Tau P; Di Nardo Stuppino S; Colella E; Carosella S; Guastavigna M; Ghisetti V; Micheli V; Galli M; Rusconi S;

Relationship between innate immunity, soluble markers and metabolic-clinical parameters in HIV+ patients ART treated with HIV-RNA<50 cp/mL. in Journal of the International AIDS Society / J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19718. doi: 10.7448/IAS.17.4.19718. eCollection 2014.

2014
ASL Città di Torino

Dentone C; Fenoglio D; Signori A; Cenderello G; Parodi A; Bozzano F; Guerra M; De Leo P; Bartolacci V; Mantia E; Orofino G; Kalli F; Marras F; Fraccaro P; Giacomini M; Cassola G; Bruzzone B; Ferrea G; Viscoli C; Filaci G; De Maria A; Di Biagio A;

Safety and therapeutic efficacy of the switch to maraviroc+darunavir/ritonavir in HIV/HCV coinfected patients: initial results from GUSTA study. in Journal of the International AIDS Society / J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19818. doi: 10.7448/IAS.17.4.19818. eCollection 2014.

2014
ASL Città di Torino

Gagliardini R; Rossetti B; Bianco C; Rusconi S; Colafigli M; Prinapori R; Francisci D; Fantauzzi A; Orofino G; Vignale F; Di Giambenedetto S; De Luca A;

Simplification to atazanavir/ritonavir+lamivudine in virologically suppressed HIV-infected patients: 24-weeks interim analysis from ATLAS-M trial. in Journal of the International AIDS Society / J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19808. doi: 10.7448/IAS.17.4.19808. eCollection 2014.

2014
ASL Città di Torino

Fabbiani M; Di Giambenedetto S; Quiros-Roldan E; Latini A; Vullo V; Antinori A; Castagna A; Orofino G; Francisci D; Grilli E; Madeddu G; Grima P; Rusconi S; Del Pin B; Mondi A; Borghetti A; Focà E; Colafigli M; De Luca A; Cauda R;